Last 12 months
Inside the activity.
0 purchase rows · 240 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 200 |
| Dec 2025 | 0 | 3 |
| Jan 2026 | 0 | 31 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 2 |
| Jun 2026 | 0 | 1 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 3 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| November 19, 2018 Filed Nov 20, 2018 22:47 UTC |
Runge Marschall SDirector
|
GrantCommon Stock | 1,511 | $115.81 | $174,988.91 |
DisclosureSEC source: 0000059478-18-000276 · wf-form4_154275402294040.xml · nonDerivative · entry 1 Runge Marschall S · CIK 0001586197 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,014 Read SEC document |
| November 19, 2018 Filed Nov 20, 2018 22:51 UTC |
SEIFERT KATHI PDirector
|
GrantCommon Stock | 1,511 | $115.81 | $174,988.91 |
DisclosureSEC source: 0000059478-18-000278 · wf-form4_154275425396796.xml · nonDerivative · entry 1 SEIFERT KATHI P · CIK 0001222893 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 71,370 Read SEC document |
| November 19, 2018 Filed Nov 20, 2018 22:53 UTC |
TAI JACKSON PDirector
|
GrantCommon Stock | 1,511 | $115.81 | $174,988.91 |
DisclosureSEC source: 0000059478-18-000280 · wf-form4_154275440903887.xml · nonDerivative · entry 1 TAI JACKSON P · CIK 0001173275 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 54,786 Read SEC document |
| November 19, 2018 Filed Nov 20, 2018 23:15 UTC |
Baicker KatherineDirector
|
GrantCommon Stock | 1,511 | $115.81 | $174,988.91 |
DisclosureSEC source: 0000059478-18-000282 · wf-form4_154275572085634.xml · nonDerivative · entry 1 Baicker Katherine · CIK 0001537067 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,797 Read SEC document |
| November 19, 2018 Filed Nov 20, 2018 23:19 UTC |
JACKSON JAMEREDirector
|
GrantCommon Stock | 1,511 | $115.81 | $174,988.91 |
DisclosureSEC source: 0000059478-18-000284 · wf-form4_154275593397414.xml · nonDerivative · entry 1 JACKSON JAMERE · CIK 0001601813 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,016 Read SEC document |
| November 19, 2018 Filed Nov 20, 2018 19:40 UTC |
LILLY ENDOWMENT INC10% owner
|
SaleCommon Stock | 99,780 | $115.65 | $11,539,557.00 |
DisclosureSEC source: 0001209191-18-059414 · doc4.xml · nonDerivative · entry 2 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 118,405,804 F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $115.40 to $116.10, inclusive. Read SEC document |
| November 19, 2018 Filed Nov 20, 2018 19:40 UTC |
LILLY ENDOWMENT INC10% owner
|
SaleCommon Stock | 95,220 | $114.96 | $10,946,015.10 |
DisclosureSEC source: 0001209191-18-059414 · doc4.xml · nonDerivative · entry 1 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 118,505,584 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $114.40 to $115.38, inclusive. The reporting person undertakes to provide to Eli Lilly & Company, any security holder of Eli Lilly & Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (1) and (2) to this Form 4. Read SEC document |
| November 16, 2018 Filed Nov 19, 2018 18:53 UTC |
LILLY ENDOWMENT INC10% owner
|
SaleCommon Stock | 200,000 | $113.74 | $22,747,000.00 |
DisclosureSEC source: 0001209191-18-059117 · doc4.xml · nonDerivative · entry 1 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 118,600,804 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $113.40 to $114.295, inclusive. The reporting person undertakes to provide to Eli Lilly & Company, any security holder of Eli Lilly & Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (1) to this Form 4. Read SEC document |
| November 13, 2018 Filed Nov 14, 2018 15:44 UTC |
LILLY ENDOWMENT INC10% owner
|
SaleCommon Stock | 2,460 | $113.41 | $278,978.76 |
DisclosureSEC source: 0001209191-18-058432 · doc4.xml · nonDerivative · entry 1 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 118,800,804 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $113.21 to $113.76, inclusive. The reporting person undertakes to provide to Eli Lilly & Company, any security holder of Eli Lilly & Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (1) to this Form 4. Read SEC document |
| November 12, 2018 Filed Nov 13, 2018 15:51 UTC |
LILLY ENDOWMENT INC10% owner
|
SaleCommon Stock | 10,900 | $114.40 | $1,246,960.00 |
DisclosureSEC source: 0001209191-18-058108 · doc4.xml · nonDerivative · entry 2 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 118,803,264 F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $114.20 to $114.68, inclusive. Read SEC document |
| November 12, 2018 Filed Nov 13, 2018 15:51 UTC |
LILLY ENDOWMENT INC10% owner
|
SaleCommon Stock | 191,640 | $113.43 | $21,737,916.84 |
DisclosureSEC source: 0001209191-18-058108 · doc4.xml · nonDerivative · entry 1 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 118,814,164 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $113.20 to $114.19, inclusive. The reporting person undertakes to provide to Eli Lilly & Company, any security holder of Eli Lilly & Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (1) and (2) to this Form 4. Read SEC document |
| November 12, 2018 Filed Feb 1, 2019 18:57 UTC |
Harrington Michael JSenior VP and General Counsel
|
GiftCommon Stock | 1,262 | $0.00 | $0.00 |
DisclosureSEC source: 0000059478-19-000014 · wf-form5_154904745815105.xml · nonDerivative · entry 3 Harrington Michael J · CIK 0001566340 · Senior VP and General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 89,770 Read SEC document |
| November 09, 2018 Filed Feb 1, 2019 19:00 UTC |
Shah Aarti S.SVP & CIO
|
GiftCommon Stock | 1,424 | $0.00 | $0.00 |
DisclosureSEC source: 0000059478-19-000016 · wf-form5_154904764268951.xml · nonDerivative · entry 1 Shah Aarti S. · CIK 0001725292 · SVP & CIO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,285 Read SEC document |
| November 09, 2018 Filed Feb 1, 2019 19:04 UTC |
Zakrowski Donald AChief Accounting Officer
|
GiftCommon Stock | 180 | $0.00 | $0.00 |
DisclosureSEC source: 0000059478-19-000018 · wf-form5_154904782815482.xml · nonDerivative · entry 1 Zakrowski Donald A · CIK 0001561539 · Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,350 Read SEC document |
| November 03, 2018 Filed Nov 6, 2018 18:25 UTC |
Norton JohnaSenior VP, Global Quality
|
Exercise / conversionRestricted Stock Unit · Derivative | 3,133 | $0.00 | $0.00 |
DisclosureSEC source: 0000059478-18-000258 · wf-form4_154152872203725.xml · derivative · entry 6 Norton Johna · CIK 0001702471 · Senior VP, Global Quality 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 3,133 shares Expires 2018-11-03 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Eli Lilly and Company common stock. Read SEC document |
| November 03, 2018 Filed Nov 6, 2018 18:25 UTC |
Norton JohnaSenior VP, Global Quality
|
Tax withholdingCommon Stock | 1,366 | $106.75 | $145,820.50 |
DisclosureSEC source: 0000059478-18-000258 · wf-form4_154152872203725.xml · nonDerivative · entry 2 Norton Johna · CIK 0001702471 · Senior VP, Global Quality 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,859 Read SEC document |
| November 03, 2018 Filed Nov 6, 2018 18:25 UTC |
Norton JohnaSenior VP, Global Quality
|
Exercise / conversionCommon Stock | 3,133 | $0.00 | $0.00 |
DisclosureSEC source: 0000059478-18-000258 · wf-form4_154152872203725.xml · nonDerivative · entry 1 Norton Johna · CIK 0001702471 · Senior VP, Global Quality 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,225 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| October 17, 2018 Filed Oct 18, 2018 18:26 UTC |
LILLY ENDOWMENT INC10% owner
|
SaleCommon Stock | 174,696 | $113.25 | $19,783,623.22 |
DisclosureSEC source: 0001209191-18-055500 · doc4.xml · nonDerivative · entry 1 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 119,005,804 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $113.00 to $113.76, inclusive. The reporting person undertakes to provide to Eli Lilly & Company, any security holder of Eli Lilly & Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (1) to this Form 4. Read SEC document |
| October 15, 2018 Filed Oct 17, 2018 20:38 UTC |
Alvarez RalphDirector
|
GrantCommon Stock | 99 | $110.62 | $10,951.38 |
DisclosureSEC source: 0000059478-18-000247 · wf-form4_153980871005058.xml · nonDerivative · entry 1 Alvarez Ralph · CIK 0001310215 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 41,491 Read SEC document |
| October 15, 2018 Filed Oct 17, 2018 20:46 UTC |
Fyrwald J ErikDirector
|
GrantCommon Stock | 49 | $110.62 | $5,420.38 |
DisclosureSEC source: 0000059478-18-000249 · wf-form4_153980918850674.xml · nonDerivative · entry 1 Fyrwald J Erik · CIK 0001343564 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 59,883 Read SEC document |
| October 15, 2018 Filed Oct 17, 2018 20:50 UTC |
LUCIANO JUAN RDirector
|
GrantCommon Stock | 87 | $110.62 | $9,623.94 |
DisclosureSEC source: 0000059478-18-000251 · wf-form4_153980940121644.xml · nonDerivative · entry 1 LUCIANO JUAN R · CIK 0001455792 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,508 Read SEC document |
| October 09, 2018 Filed Oct 10, 2018 17:17 UTC |
LILLY ENDOWMENT INC10% owner
|
SaleCommon Stock | 10,672 | $115.91 | $1,237,012.86 |
DisclosureSEC source: 0001209191-18-054625 · doc4.xml · nonDerivative · entry 1 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 119,180,500 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $115.90 to $115.99, inclusive. The reporting person undertakes to provide to Eli Lilly & Company, any security holder of Eli Lilly & Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (1) to this Form 4. Read SEC document |
| October 08, 2018 Filed Oct 9, 2018 17:14 UTC |
LILLY ENDOWMENT INC10% owner
|
SaleCommon Stock | 14,632 | $115.91 | $1,696,039.02 |
DisclosureSEC source: 0001209191-18-054485 · doc4.xml · nonDerivative · entry 1 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 119,191,172 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $115.90 to $115.9853, inclusive. The reporting person undertakes to provide to Eli Lilly & Company, any security holder of Eli Lilly & Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (1) to this Form 4. Read SEC document |
| October 04, 2018 Filed Oct 5, 2018 18:08 UTC |
Zulueta Alfonso GSVP & President, Lilly Int'l
|
SaleCommon Stock | 7,000 | $114.64 | $802,480.00 |
DisclosureSEC source: 0000059478-18-000240 · wf-form4_153876291479874.xml · nonDerivative · entry 1 Zulueta Alfonso G · CIK 0001596336 · SVP & President, Lilly Int'l 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 45,224 F1 · kind: The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 15, 2018. F2 · price: This transaction was executed in multiple trades at prices ranging from $114.17 to $115.00. The price reported reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| October 04, 2018 Filed Oct 5, 2018 18:47 UTC |
LILLY ENDOWMENT INC10% owner
|
SaleCommon Stock | 500 | $115.51 | $57,753.00 |
DisclosureSEC source: 0001209191-18-054354 · doc4.xml · nonDerivative · entry 5 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 119,205,804 F5 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $115.35 to $115.64, inclusive. Read SEC document |
| October 04, 2018 Filed Oct 5, 2018 18:47 UTC |
LILLY ENDOWMENT INC10% owner
|
SaleCommon Stock | 4,779 | $114.70 | $548,165.64 |
DisclosureSEC source: 0001209191-18-054354 · doc4.xml · nonDerivative · entry 4 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 119,206,304 F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $114.35 to $115.31, inclusive. Read SEC document |
| October 04, 2018 Filed Oct 5, 2018 18:47 UTC |
LILLY ENDOWMENT INC10% owner
|
SaleCommon Stock | 14,685 | $113.74 | $1,670,227.85 |
DisclosureSEC source: 0001209191-18-054354 · doc4.xml · nonDerivative · entry 3 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 119,211,083 F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $113.12 to $114.11, inclusive. Read SEC document |
| October 04, 2018 Filed Oct 5, 2018 18:47 UTC |
LILLY ENDOWMENT INC10% owner
|
SaleCommon Stock | 66,533 | $112.65 | $7,495,208.58 |
DisclosureSEC source: 0001209191-18-054354 · doc4.xml · nonDerivative · entry 2 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 119,225,768 F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $112.12 to $113.115, inclusive. Read SEC document |
| October 04, 2018 Filed Oct 5, 2018 18:47 UTC |
LILLY ENDOWMENT INC10% owner
|
SaleCommon Stock | 29,541 | $111.80 | $3,302,595.18 |
DisclosureSEC source: 0001209191-18-054354 · doc4.xml · nonDerivative · entry 1 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 119,292,301 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $111.12 to $112.11, inclusive. The reporting person undertakes to provide to Eli Lilly & Company, any security holder of Eli Lilly & Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (1), (2), (3), (4), and (5) to this Form 4. Read SEC document |
| October 03, 2018 Filed Oct 4, 2018 18:29 UTC |
LILLY ENDOWMENT INC10% owner
|
SaleCommon Stock | 78,962 | $109.01 | $8,607,252.81 |
DisclosureSEC source: 0001209191-18-054223 · doc4.xml · nonDerivative · entry 1 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 119,321,842 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $108.90 to $109.55, inclusive. The reporting person undertakes to provide to Eli Lilly & Company, any security holder of Eli Lilly & Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (1) to this Form 4. Read SEC document |
| September 28, 2018 Filed Oct 1, 2018 15:53 UTC |
LILLY ENDOWMENT INC10% owner
|
SaleCommon Stock | 107,553 | $107.31 | $11,541,082.22 |
DisclosureSEC source: 0001209191-18-052648 · doc4.xml · nonDerivative · entry 1 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 119,400,804 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $106.90 to $107.73, inclusive. The reporting person undertakes to provide to Eli Lilly & Company, any security holder of Eli Lilly & Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (1) to this Form 4. Read SEC document |
| September 27, 2018 Filed Sep 28, 2018 14:36 UTC |
LILLY ENDOWMENT INC10% owner
|
SaleCommon Stock | 92,447 | $107.00 | $9,891,644.11 |
DisclosureSEC source: 0001209191-18-052529 · doc4.xml · nonDerivative · entry 1 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 119,508,357 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $106.90 to $107.16, inclusive. The reporting person undertakes to provide to Eli Lilly & Company, any security holder of Eli Lilly & Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (1) to this Form 4. Read SEC document |
| September 26, 2018 Filed Sep 27, 2018 16:26 UTC |
LILLY ENDOWMENT INC10% owner
|
SaleCommon Stock | 1,500 | $107.32 | $160,977.00 |
DisclosureSEC source: 0001209191-18-052398 · doc4.xml · nonDerivative · entry 2 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 119,600,804 F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $107.255 to $107.35, inclusive. Read SEC document |
| September 26, 2018 Filed Sep 27, 2018 16:26 UTC |
LILLY ENDOWMENT INC10% owner
|
SaleCommon Stock | 132,910 | $106.62 | $14,171,395.84 |
DisclosureSEC source: 0001209191-18-052398 · doc4.xml · nonDerivative · entry 1 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 119,602,304 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $106.25 to $107.23, inclusive. The reporting person undertakes to provide to Eli Lilly & Company, any security holder of Eli Lilly & Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (1) and (2) to this Form 4. Read SEC document |
| September 25, 2018 Filed Sep 26, 2018 17:49 UTC |
LILLY ENDOWMENT INC10% owner
|
SaleCommon Stock | 55,590 | $106.41 | $5,915,165.13 |
DisclosureSEC source: 0001209191-18-052257 · doc4.xml · nonDerivative · entry 1 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 119,735,214 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $106.25 to $106.59, inclusive. The reporting person undertakes to provide to Eli Lilly & Company, any security holder of Eli Lilly & Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (1) to this Form 4. Read SEC document |
| September 18, 2018 Filed Sep 19, 2018 21:47 UTC |
Zulueta Alfonso GSVP & President, Lilly Int'l
|
SaleCommon Stock | 3,000 | $107.00 | $321,000.00 |
DisclosureSEC source: 0000059478-18-000225 · wf-form4_153739365291067.xml · nonDerivative · entry 2 Zulueta Alfonso G · CIK 0001596336 · SVP & President, Lilly Int'l 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 52,224 F1 · kind: The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 15, 2018. Read SEC document |
| September 17, 2018 Filed Sep 19, 2018 21:47 UTC |
Zulueta Alfonso GSVP & President, Lilly Int'l
|
SaleCommon Stock | 3,000 | $105.61 | $316,830.00 |
DisclosureSEC source: 0000059478-18-000225 · wf-form4_153739365291067.xml · nonDerivative · entry 1 Zulueta Alfonso G · CIK 0001596336 · SVP & President, Lilly Int'l 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 55,224 F1 · kind: The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 15, 2018. Read SEC document |
| September 17, 2018 Filed Sep 19, 2018 21:49 UTC |
Alvarez RalphDirector
|
GrantCommon Stock | 105 | $105.71 | $11,099.55 |
DisclosureSEC source: 0000059478-18-000226 · wf-form4_153739372778603.xml · nonDerivative · entry 1 Alvarez Ralph · CIK 0001310215 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 41,392 Read SEC document |
| September 17, 2018 Filed Sep 19, 2018 21:53 UTC |
Fyrwald J ErikDirector
|
GrantCommon Stock | 120 | $105.71 | $12,685.20 |
DisclosureSEC source: 0000059478-18-000228 · wf-form4_153739396725969.xml · nonDerivative · entry 1 Fyrwald J Erik · CIK 0001343564 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 59,834 Read SEC document |
| September 17, 2018 Filed Sep 19, 2018 21:57 UTC |
LUCIANO JUAN RDirector
|
GrantCommon Stock | 87 | $105.71 | $9,196.77 |
DisclosureSEC source: 0000059478-18-000230 · wf-form4_153739421626197.xml · nonDerivative · entry 1 LUCIANO JUAN R · CIK 0001455792 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,421 Read SEC document |
| September 07, 2018 Filed Sep 10, 2018 16:44 UTC |
LILLY ENDOWMENT INC10% owner
|
SaleCommon Stock | 41,949 | $107.08 | $4,491,982.82 |
DisclosureSEC source: 0001209191-18-050196 · doc4.xml · nonDerivative · entry 2 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 119,790,804 F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $107.00 to $107.23, inclusive. Read SEC document |
| September 07, 2018 Filed Sep 10, 2018 16:44 UTC |
LILLY ENDOWMENT INC10% owner
|
SaleCommon Stock | 138,051 | $106.66 | $14,725,071.86 |
DisclosureSEC source: 0001209191-18-050196 · doc4.xml · nonDerivative · entry 1 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 119,832,753 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $106.00 to $106.9914, inclusive. The reporting person undertakes to provide to Eli Lilly & Company, any security holder of Eli Lilly & Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (1) and (2) to this Form 4. Read SEC document |
| September 04, 2018 Filed Sep 4, 2018 20:50 UTC |
Zakrowski Donald AChief Accounting Officer
|
SaleCommon Stock | 600 | $105.57 | $63,342.00 |
DisclosureSEC source: 0000059478-18-000214 · wf-form4_153609422893951.xml · nonDerivative · entry 1 Zakrowski Donald A · CIK 0001561539 · Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,530 F1 · kind: The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 1, 2018. Read SEC document |
| August 30, 2018 Filed Aug 31, 2018 13:07 UTC |
LILLY ENDOWMENT INC10% owner
|
SaleCommon Stock | 190,000 | $105.42 | $20,030,370.00 |
DisclosureSEC source: 0001209191-18-049028 · doc4.xml · nonDerivative · entry 1 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 119,970,804 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $105.40 to $105.63, inclusive. The reporting person undertakes to provide to Eli Lilly & Company, any security holder of Eli Lilly & Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (1) to this Form 4. Read SEC document |
| August 20, 2018 Filed Aug 21, 2018 16:58 UTC |
Alvarez RalphDirector
|
GrantCommon Stock | 103 | $105.82 | $10,899.46 |
DisclosureSEC source: 0000059478-18-000204 · wf-form4_153487069633902.xml · nonDerivative · entry 1 Alvarez Ralph · CIK 0001310215 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 41,071 Read SEC document |
| August 20, 2018 Filed Aug 21, 2018 17:04 UTC |
Fyrwald J ErikDirector
|
GrantCommon Stock | 51 | $105.82 | $5,396.82 |
DisclosureSEC source: 0000059478-18-000206 · wf-form4_153487104416669.xml · nonDerivative · entry 1 Fyrwald J Erik · CIK 0001343564 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 59,401 Read SEC document |
| August 20, 2018 Filed Aug 21, 2018 17:11 UTC |
LUCIANO JUAN RDirector
|
GrantCommon Stock | 91 | $105.82 | $9,629.62 |
DisclosureSEC source: 0000059478-18-000208 · wf-form4_153487144893424.xml · nonDerivative · entry 1 LUCIANO JUAN R · CIK 0001455792 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,302 Read SEC document |
| August 20, 2018 Filed Aug 21, 2018 18:12 UTC |
LILLY ENDOWMENT INC10% owner
|
SaleCommon Stock | 195,000 | $105.89 | $20,647,575.00 |
DisclosureSEC source: 0001209191-18-047721 · doc4.xml · nonDerivative · entry 1 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 120,160,804 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $105.70 to $106.26, inclusive. The reporting person undertakes to provide to Eli Lilly & Company, any security holder of Eli Lilly & Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (1) to this Form 4. Read SEC document |
| August 16, 2018 Filed Aug 17, 2018 19:08 UTC |
LILLY ENDOWMENT INC10% owner
|
SaleCommon Stock | 200,000 | $104.50 | $20,899,800.00 |
DisclosureSEC source: 0001209191-18-047294 · doc4.xml · nonDerivative · entry 1 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 120,355,804 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $104.20 to $104.88, inclusive. The reporting person undertakes to provide to Eli Lilly & Company, any security holder of Eli Lilly & Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (1) to this Form 4. Read SEC document |
| August 15, 2018 Filed Aug 16, 2018 18:52 UTC |
LILLY ENDOWMENT INC10% owner
|
SaleCommon Stock | 151,793 | $103.23 | $15,669,439.60 |
DisclosureSEC source: 0001209191-18-046997 · doc4.xml · nonDerivative · entry 1 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 120,555,804 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $103.00 to $103.43, inclusive. The reporting person undertakes to provide to Eli Lilly & Company, any security holder of Eli Lilly & Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (1) to this Form 4. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.